Profitability
Weight: 25%
C
51
- 5yr Avg ROIC 10.9%
- Operating Margin Trend -1.01 pp/yr
HRMY
Harmony Biosciences Holdings, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
B+
76
- 5yr Avg ROE 14.9%
- 5yr Share-Count CAGR -0.3%
Growth Quality
Weight: 25%
A+
100
- 5yr Revenue CAGR 29.9%
- 5yr EPS CAGR 47.0%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
A
93
- 5yr FCF Margin 34.7%
- 5yr FCF/NI Conversion 1.81x
Balance Sheet
Weight: 10%
A+
98
- Net Debt / EBITDA -2.10x
- Interest Coverage (EBIT/Int) 15.68x
- Altman Z-Score 4.91
Stability
Weight: 5%
C+
59
- EPS Volatility (σ/μ) 0.43
- Piotroski F-Score 5
- Negative-Revenue Years (5) 0/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.3 of 3 gurus held; 2 added; 1 trimmed; 1 full exit.
- Holders
- 3
- Avg Δ position
- +33.6%
- New buys
- 0
- Full exits
- 1
- Wood sold -100%
- Greenblatt increased +102%
- Cooperman decreased -11%